ReposiTrak (NYSE:TRAK) CEO Sells $13,120.00 in Stock

Key Points

  • CEO Randall Fields sold 6,500 shares of ReposiTrak on Nov. 25 at an average price of $13.18 for $85,670, trimming his stake by 3.19% to 197,500 shares valued at about $2.60 million.
  • Shares opened at $13.22 (up ~1.8%), with a 12‑month range of $12.90–$25.01 and a market cap of $241.8 million; the company reported last quarter EPS of $0.09 on $5.97 million revenue, a 30.6% net margin, and strong liquidity (quick/current ratio 6.09) with negligible debt (debt/equity 0.01).
  • Analysts have an average rating of "Hold" after recent downgrades, and institutional investors own about 27.35% of the stock with several funds recently adding or increasing positions.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 1,000 shares of the business's stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $13.12, for a total transaction of $13,120.00. Following the sale, the chief executive officer directly owned 204,000 shares of the company's stock, valued at approximately $2,676,480. The trade was a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

ReposiTrak Stock Performance

Shares of NYSE TRAK opened at $13.22 on Wednesday. The company has a market cap of $241.77 million, a PE ratio of 37.77 and a beta of 0.39. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.09 and a current ratio of 6.09. ReposiTrak Inc. has a fifty-two week low of $12.90 and a fifty-two week high of $25.01. The company has a 50-day simple moving average of $15.23.

ReposiTrak (NYSE:TRAK - Get Free Report) last issued its quarterly earnings data on Thursday, November 13th. The company reported $0.09 EPS for the quarter. ReposiTrak had a return on equity of 14.25% and a net margin of 30.55%.The firm had revenue of $5.97 million during the quarter.

Analyst Ratings Changes




A number of research firms recently commented on TRAK. Weiss Ratings reissued a "hold (c)" rating on shares of ReposiTrak in a research report on Wednesday, November 19th. Wall Street Zen lowered shares of ReposiTrak from a "buy" rating to a "hold" rating in a research note on Friday, October 3rd. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of "Hold".

Read Our Latest Report on TRAK

Institutional Trading of ReposiTrak

A number of hedge funds have recently bought and sold shares of TRAK. BNP Paribas Financial Markets boosted its position in ReposiTrak by 63.5% in the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock worth $32,000 after purchasing an additional 634 shares during the last quarter. Copeland Capital Management LLC bought a new stake in ReposiTrak in the 3rd quarter valued at about $54,000. Tower Research Capital LLC TRC grew its stake in ReposiTrak by 397.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock valued at $71,000 after buying an additional 2,892 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in ReposiTrak during the 3rd quarter worth about $219,000. Finally, R Squared Ltd bought a new stake in ReposiTrak during the 2nd quarter worth approximately $235,000. 27.35% of the stock is currently owned by institutional investors.

ReposiTrak Company Profile

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Featured Articles

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at ReposiTrak?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ReposiTrak and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles